General 1 Flashcards

(49 cards)

1
Q

Vitamin B-12 aka

A

cobalamin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what vitamin is Folic Acid

A

B9

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

COMPASS study - anacronym means ?

A
Cardiovascular 
Outomes for 
People 
Using
Anticoagulation 
Strategies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

COMPASS study LIMA failure rate

A

6.4% at one year

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

COMPASS study Radial artery failure rate

A

9.9% at one year

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

COMPASS study - SVG failure rate at one year

A

10.4%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

COMPASS Study - RIMA failure rate at one year

A

26.4%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

COMPASS study - LIMA patency is related to

A

Target vessel stenosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

COMPASS study - 1 year SVG patency is related to

A

Target vessel quality and proximal location

composite or sequential had worse patency than direct to the aorta

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Definition of vasoplegia

A

unified definition
if they had following conditions for at least three consecutive hours during the first 48 h after ICU arrival:
*a vasodilation criterion: *
1. MAP ≤50 mmHg or SVR ≤800 dynes·s·cm− 5;
* hemodynamic criterion: *
1. CI ≥ 2.5 l·min− 1·m− 2;
*high vasopressor requirement:**
use of norepinephrine ≥200 ng·kg− 1·min− 1 or equivalent doses of vasopressors (epinephrine ≥200 ng·kg− 1·min− 1; dopamine ≥30 μg·kg− 1·min− 1; phenylephrine ≥2 μg·kg− 1·min− 1, or vasopressin ≥0.08 U·min− 1)
proposed in the ATHOS-3 trial
**

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

The estimated annualized rate of sudden death for asymptomatic patients with severe AS is?

A

The estimated annualized rate of sudden death for asymptomatic patients with severe AS is 1% per year

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

operative mortality associated with sAVR in patients aged <70?

A

Operative mortality associated with sAVR
age < 70: 1%–3%
age > 70: 3%–8%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

operative mortality associated with sAVR in patients > 70 years?

A

operative mortality associated with sAVR in patients
> 70 years: 3%–8%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Indications for sAVR in aysmptomatic AS patients with low surgical risk ?

A

Vmax presenting a low surgical risk (class IIa recommendation)
≥5 m/s in US guidelines
>5.5 m/s in European guidelines

Finally, the latest European guidelines add:
* markedly elevated brain natriuretic peptide (BNP) levels
* severe pulmonary hypertension at rest (systolic pulmonary artery pressure >60 mm Hg)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Other parameters validated as strong predictors of poor outcome in asymptomatic severe AS?

might represent incentives for AVR referral:

A

indexed stroke volume by Doppler echocardiography
* <30mL/m2)
LVEF
* between 50% and 55%,
left atrial enlargement
* left atrial volume >95mL or
* indexed left atrial volume >50mL/m2in patients in sinus rhythm).
*

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Indicators of very severe aortic stenosis

A

Peak aortic jet velocity: >5m/s
MTAPG: > 60 mmHg
AVA: 0.6 cm 2
Indexed Aortic valve area :
0.4 cm/m2 (BSA)
0.45 cm/m (height)
Dimensionless index: < 0.2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Dimensionless index for
1. Severe AS
2. Very severe AS

A

Severe AS: <0.25
Very severe AS: <0.2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Peak aortic velocity for Very severe AS

A

> 5m/s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

MATPG for very severe AS?

A

> 60 mmHg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Mean AVA for very severe AS ?

21
Q

severe aortic stenosis

Indexed aortic valve area

A

0.4 cm2/m2
0.45 cm2/m

22
Q

B vitamin for vasoplegia

A

hydroxocobalamin

23
Q

mechanism of action for

hydroxocobalamin

for Vasoplegia

A

free NO scavenger (similar to methelene blue)

24
Q

Vasoplegia

Dose for hydroxocobalamin

A

2 mg/kg bolus
* one of the patients receiving an additional 0.5 mg/kg/hr for 6 hours

25
what level of Bilirubin is associated with jaundice
2.5-3 mg/dl
26
louche
disreputable or sordid in a rakish or appealing way. "the louche world of the theater" louche /lo͞oSH/ adjective adjective: louche; comparative adjective: loucher; superlative adjective: louchest
27
tel·e·o·log·i·cal
/ˌtelēəˈläjəkəl/ adjective PHILOSOPHY relating to or involving the explanation of phenomena in terms of the purpose they serve rather than of the cause by which they arise.
28
heu·ris·tic /hyo͝oˈristik/
heu·ris·tic /hyo͝oˈristik/ adjective 1. enabling someone to discover or learn something for themselves. "a “hands-on” or interactive heuristic approach to learning" 2. COMPUTING proceeding to a solution by trial and error or by rules that are only loosely defined.
29
Epistemology —
Epistemology — The theory of knowledge. The method of what distinguishes belief from opinion.
30
Cardiac power output
MAP x CO/451 Shock < 0.6W
31
Cardiac power index
MAP x CI / 451 Shock < 0.4 W/m2
32
Description of SCAI A shock
* **A**t Risk not currently experiencing signs or symptoms of CS at risk for its development. may include: those with large acute MI or prior MI and/or acute on chronic heart failure symptoms.
33
# Description of Physical Exam SCAI A Shock
Normal JVP Lung sounds clear Warm and well perfused * Strong distal pulses * Normal mentation
34
Descripton of SCAI A biochemical markers
Normal labs * Normal renal function * Normal lactic acid
35
SCAI A Hemodynamics
Normotensive (SBP≥100 or normal for pt.) If hemodynamics done * cardiac index ≥2.5 * CVP <10 * PA sat ≥65%
36
Fried Frailty
1. Weight loss 2. Exhaustion 3. Low Physical activity 4. Slowness (gait speed ) 5. Weakness
37
VT Storm
cardiac electrical instability characterized by: multiple episodes of ventricular tachycardia (VT storm) ventricular fibrillation (VF storm) within a relatively short period of time, typically 24 hours
38
Clinical Signs and symptoms of RHF
1. Positive JVD 2. Peripheral Edema 3. Bloating/Ascites 4. Fatigue 5. Bilirubin elevation 6. Creatinine elevation 7. Lactate elevation
39
Hemodynamic criteria for RHF
 Decreased systolic pressure <90 mmHg  Cardiac index <2.2 L/min/m²  CVP >15 mmHg  RAP/PCWP >0.8  PAPi <1.5  Decreased SvO2 <60%  Mean PA >20 mmHg
40
RAP/PCWP indicative of RHF
RAP/PCWP >0.8
41
Mean PA pressure indicative of RHF
Mean PA >20 mmHg
42
systolic pressure indicative of right heart failure
systolic pressure <90 mmHg
43
PAPi indicative of right heart failure
PAPi <1.5
44
Quantitative ECHO signs consistent with RHF
 TAPSE <17 mm  RV basilar diameter >42 mm  RV mid-cavity diameter >35 mm  Global hypokinesis  IVC evaluation >2.5cm  Septal bowing into LV  Tricuspid regurgitation
45
TAPSE consistent with right heart failure ?
 TAPSE <17 mm
46
RV basilar diameter consistent with right heart failure ?
RV basilar diameter >42 mm
47
RV mid-cavity diameter consistent with right heart failure ?
RV mid-cavity diameter >35 mm
48
 IVC diameter consistent with right heart failure ?
 IVC evaluation >2.5cm
49
PAPi consistent with RHF in an LVAD supported patient
 PAPi <1.85